News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

 

FDA approves Afinitor for brain tumor treatment



Website: http://www.reuters.com/article/idUSN2926831720101030

Posted on: 10/30/2010

UPDATE 1-FDA approves Afinitor for brain tumor treatment

 
 
 

Stocks

 
Novartis AG
NOVN.VX
CHF57.05
+0.25+0.44%
12:00am EDT
 
 
 
 

NEW YORK | Fri Oct 29, 2010 11:10pm EDT

Oct 29 (Reuters) - The Food and Drug Administration has approved Novartis AG's (NOVN.VX) Afinitor to treat benign brain tumors, Novartis said on Friday.

The drug can be used to treat adults and children with benign brain tumors associated with tuberous sclerosis, a genetic disorder that may cause tumors to form in vital organs.

Prior to the approval, the only option to treat this form of tumor was surgery, according to Novartis.

The approval was based on a 28-patient study which showed that nearly one-third of patients had at least a 50 percent reduction in their largest tumors after six months.

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740